Merit Medical Systems, Inc. (NASDAQ:MMSI) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition.
issued a press release announcing its operating and financial
results for the quarter and year ended December 31, 2016. The full
text of the Company’s press release, including unaudited financial
information, is furnished herewith as Exhibit 99.1.
exhibits attached hereto) is furnished to General Instruction B.2.
of Form 8-K and shall not be deemed to be “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), or otherwise subject to the liabilities of that
section, nor shall it be deemed incorporated by reference in any
filing made by the Company under the Securities Act of 1933, as
amended (the “Securities Act”), or the Exchange Act, except as
expressly set forth by specific reference in such a filing.
conference call for the purpose of discussing its operating and
financial results for the quarter and year ended December 31, 2016.
In connection with that call, the Company posted a slide
presentation to its website. The presentation discusses the
Company’s operating and financial results for the quarter and year
ended December 31, 2016, as well as the Companys outlook for its
future operations and financial performance. A copy of the
presentation is attached herewith as Exhibit 99.2.
(including Exhibit 99.2 attached hereto) to Regulation FD
promulgated under the Exchange Act. Such information shall not be
deemed filed for purposes of the Exchange Act or otherwise subject
to the liabilities of that section, and is not deemed incorporated
by reference into any filing under the Securities Act, except as
expressly set forth by specific reference in such a filing.
|
99.1
|
|
Press Release, dated February 21, 2017, entitled “Merit
Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016,” including unaudited financial information. |
|
99.2
|
|
Conference Call Presentation.
|
About Merit Medical Systems, Inc. (NASDAQ:MMSI)
Merit Medical Systems, Inc. is a designer, developer, manufacturer and marketer of medical devices used in an array of interventional and diagnostic procedures. The Company operates in two segments: cardiovascular and endoscopy. Its cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases; embolotherapeutic products, and cardiac rhythm management and electrophysiology (CRM/EP) devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its products are used in various clinical areas, such as diagnostic and interventional cardiology; interventional radiology; vascular, general and thoracic surgery; interventional pulmonology; interventional nephrology; oncology, and pain management. Merit Medical Systems, Inc. (NASDAQ:MMSI) Recent Trading Information
Merit Medical Systems, Inc. (NASDAQ:MMSI) closed its last trading session up +0.40 at 28.65 with 357,578 shares trading hands.
